Imisopasem manganese

Drug Profile

Imisopasem manganese

Alternative Names: M 40403; Superoxide dismutase mimic - MetaPhore

Latest Information Update: 27 May 2008

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator MetaPhore Pharmaceuticals
  • Developer ActivBiotics; MetaPhore Pharmaceuticals
  • Class Analgesics; Anti-inflammatories; Anti-ischaemics; Macrocyclic compounds; Oxidoreductases; Small molecules
  • Mechanism of Action Superoxide dismutase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Mucositis
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Cancer; Cancer pain; Pain; Postoperative pain; Stomatitis

Most Recent Events

  • 02 Apr 2008 ActivBiotics sells its intellectual property assets including drug product candidates
  • 07 Mar 2008 Imisopasem manganese received Orphan Drug status for Stomatitis in USA
  • 05 Feb 2008 Imisopasem manganese received Orphan Drug status for Stomatitis in European Union
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top